Voyager Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.60
|
|
Average Rating
|
3.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
5
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.32
|
0.45
|
0.77
|
240.63%
|
|
2022-06-30
|
-0.32
|
-0.50
|
-0.18
|
-56.25%
|
|
2022-03-31
|
-0.34
|
-0.56
|
-0.22
|
-64.71%
|
|
2021-12-31
|
-0.32
|
0.15
|
0.47
|
146.88%
|
|
2021-09-30
|
-0.73
|
-0.67
|
0.06
|
8.22%
|
|
2021-06-30
|
-0.71
|
-0.80
|
-0.09
|
-12.68%
|
|
2021-03-31
|
-0.66
|
-0.58
|
0.08
|
12.12%
|
|
2020-12-31
|
-0.56
|
-0.43
|
0.13
|
23.21%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.61
|
|
2021-12-31
|
-1.90
|
|
2020-12-31
|
0.95
|
|
2019-12-31
|
-1.27
|
|
2018-12-31
|
-2.76
|
|
2017-12-31
|
-2.67
|
|
2016-12-31
|
-1.58
|
|
2015-12-31
|
-5.92
|